Faced with a depressed economy, OKYO Pharma Limited (OKYO) Stock offers an opportunity

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated 18.75% within the last five trades and 0.59% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 36.80% in the last 6 months and -2.29% was subtracted to its value over the previous 3 months. OKYO stock is trading at a margin of 10.30%, 2.22% and 4.15% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, OKYO deals in the Healthcare domain. The stock is trading -75.57 percent below its 52-week high and 85.85 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -31.86. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


What Does OKYO Pharma Limited’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $43.64 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 27.83 percent of OKYO Pharma Limited shares are owned by insiders, and 0.37 percent are held by financial institutions. BRANCACCIO JOHN P, the Director at OKYO Pharma Limited (OKYO) has bought 16,670 shares of firm on Sep 15 at a price of $1.50 against the total amount of $25005.0.

Most Popular

Related Posts